Sun.Dec 10, 2023

article thumbnail

ASH: Roche offers glimpse of Columvi-Polivy combo's early lymphoma data as phase 3 kicks off

Fierce Pharma

Roche’s blood cancer portfolio is booming with new life thanks to the antibody-drug conjugate Polivy and bispecifics. | As Roche’s blood cancer portfolio booms with new life thanks to the antibody-drug conjugate Polivy and bispecifics, the company is offering a look at data for two combinations of those drugs that support two phase 3 trials in diffuse large B-cell lymphoma.

191
191
article thumbnail

5 Trends Shaping Healthcare Business Strategies for 2024

MedCity News

Deloitte released a report predicting the key trends that will shape the healthcare landscape in 2024. Some of them include hospital M&A, health systems outsourcing departments and the increasing adoption of generative AI tools.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Explore Ashland's Latest Innovation - Viatel™ Ultrapure Bioresorbable Polymers

PharmaTech

Ashland has launched Viatel™ ultrapure bioresorbable polymers (lactide / glycolide / caprolactone chemistries), a higher purity platform of controlled release polymers used in long acting injectables and implants (LAII). Ultrapure provides improved release consistency, extended-release durations and are better suited for sensitive drug compounds due to the less acidic micro-environment.

52
article thumbnail

The Need for an Upstream Approach to Address the Youth Mental Health Crisis

MedCity News

Shifting the healthcare system to an upstream approach will take a lot of work, but young people desperately need it, and the healthcare system direly needs it as well.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

How to Choose the Best Online Milk: A Buyer's Guide to Dairy Delights

Contrarian Sales Techniques

If you're like me, you know that a good glass of milk isn't just a drink. It's a delightful experience. But with the digital era in full swing, buying milk has transcended beyond the traditional grocery aisles. Online milk shopping? Yes, it's a thing, and I'm here to tell you all about it. Why Go Online for Milk? Convenience at Your Fingertips One of the biggest draws for me is the sheer convenience.

article thumbnail

Solving One of the Most Overlooked Complications after Surgery: Medical Adhesive Related Skin Injuries

MedCity News

Selection of the correct wound dressings and closure devices for patients remains an important factor in preventing MARSIs (Medical Adhesive Related Skin Injuries).

Medical 104

More Trending

article thumbnail

Some of Your Doctors’ Best Qualities are the Same Ones Stifling Your Healthcare Experience

MedCity News

Although problems in US healthcare abound, the most insidious challenges are often tightly coupled with the industry’s most appealing and instilled virtues — a highly selective and independent workforce, (b) an extremely low tolerance for risk, and (c) a high degree of professional oversight.

Doctors 94
article thumbnail

Pharmaceutical Executive: December 2023 Issue (PDF)

PharmExec

Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.

article thumbnail

On Heels of ASH Data, Pfizer Eyes FDA Submission for New Hemophilia Drug

MedCity News

Pfizer already reported its experimental drug for hemophilia A and B met a pivotal study’s goals of reducing bleeding episodes. During the annual meeting of the American Society of Hematology, the company presented a full look at the results, which are expected to support regulatory submissions soon.

FDA 84
article thumbnail

Gender Gap in NIH-Awarded Research Grants Persists in the Field of Non-Malignant Hematology

Pharmacy Times

The study results shine a light on the potential need for further policy changes that promote gender equity and bridge the gap in R01 funding awarded to female applicants.

52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Aggressive Selling: The High-Stakes Game of Push and Profit

Contrarian Sales Techniques

The Art of Pressure: Unpacking Aggressive Sales Tactics In the fast-paced world of commerce, aggressive selling has become a ubiquitous and, at times, controversial strategy. This approach, often synonymous with high-pressure tactics, aims to accelerate consumer decision-making, frequently pushing them towards a purchase they might not have otherwise made.

Ethics 40
article thumbnail

Golidocitinib Demonstrates Significant Survival Benefits For Patients with Peripheral T-cell Lymphoma

Pharmacy Times

Median overall survival is set to be more than 2 years, which is more than double the overall survival of current frontline therapies.

article thumbnail

The Data-Driven Advantage: Utilizing Analytics for Smarter Call Planning in Pharma

Contrarian Sales Techniques

Calling All Pharma Sales Managers: It's Time to Go Data-Driven In the high-pressure world of pharmaceutical sales, every minute counts. You're juggling territories, managing reps, and constantly looking for ways to squeeze more productivity out of each workday. That's where call planning comes in. It's your secret weapon for maximizing your team's efficiency and driving those sales numbers up.

Pharma 40
article thumbnail

CSL sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for CSL here.

52
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

ASH President Speaks on Pharmacists, Novel Innovations in Hematology

Pharmacy Times

He also provides insight for students training in classical hematology, oncology hematology, or oncology pharmacy.

article thumbnail

CSL sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for CSL here.

52
article thumbnail

Reflecting on 2023

PharmExec

Another year in the books.

52
article thumbnail

United Laboratories International sees highest patent filings and grants during July in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for United Laboratories International here.

40
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL

Pharmacy Times

This is the first trial to show that a MRD-guided approach with treatment beyond MRD negativity has a significant advantage over chemotherapy, both in terms of PFS and OS.

29
article thumbnail

United Laboratories International sees highest patent filings and grants during July in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for United Laboratories International here.

40
article thumbnail

Sun Pharmaceutical Industries sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.

article thumbnail

Sun Pharmaceutical Industries sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Hisamitsu Pharmaceutical sees highest patent filings and grants during September in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Hisamitsu Pharmaceutical here.

article thumbnail

Hisamitsu Pharmaceutical sees highest patent filings and grants during September in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Hisamitsu Pharmaceutical here.

article thumbnail

Cosmo Pharmaceuticals sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.

article thumbnail

Cosmo Pharmaceuticals sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Daewoong sees highest patent filings and grants during July in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Daewoong here.

40
article thumbnail

Almirall sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Almirall here.

40
article thumbnail

Daewoong sees highest patent filings and grants during July in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Daewoong here.

40
article thumbnail

Almirall sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Almirall here.

40
article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.